Asker Healthcare Group (ASKER) Stock Overview
Provides medical supplies, devices, and equipment, and related solutions that support patient care. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ASKER Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Asker Healthcare Group AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 84.03 |
| 52 Week High | SEK 131.22 |
| 52 Week Low | SEK 71.40 |
| Beta | 0 |
| 1 Month Change | -11.45% |
| 3 Month Change | -19.20% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0.39% |
Recent News & Updates
We Think Asker Healthcare Group (STO:ASKER) Can Stay On Top Of Its Debt
Aug 26
Asker Healthcare Group's (STO:ASKER) Solid Earnings Are Supported By Other Strong Factors
Jul 30Shareholder Returns
| ASKER | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0.04% | 1.4% | 2.7% |
| 1Y | n/a | -19.2% | -1.2% |
Return vs Industry: Insufficient data to determine how ASKER performed against the Swedish Medical Equipment industry.
Return vs Market: Insufficient data to determine how ASKER performed against the Swedish Market.
Price Volatility
| ASKER volatility | |
|---|---|
| ASKER Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in SE Market | 12.1% |
| 10% least volatile stocks in SE Market | 3.0% |
Stable Share Price: ASKER has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: ASKER's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 4,266 | Johan Falk | www.asker.com |
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating rooms, polyclinics, and day surgeries; hygiene equipment; equipment and products for beauty clinics; defibrillators and wound care products; and health-related protection and trauma products for emergency care, police service, and military.
Asker Healthcare Group AB Fundamentals Summary
| ASKER fundamental statistics | |
|---|---|
| Market cap | SEK 32.19b |
| Earnings (TTM) | SEK 431.00m |
| Revenue (TTM) | SEK 15.88b |
Is ASKER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASKER income statement (TTM) | |
|---|---|
| Revenue | SEK 15.88b |
| Cost of Revenue | SEK 9.52b |
| Gross Profit | SEK 6.36b |
| Other Expenses | SEK 5.93b |
| Earnings | SEK 431.00m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 06, 2025
| Earnings per share (EPS) | 1.13 |
| Gross Margin | 40.04% |
| Net Profit Margin | 2.71% |
| Debt/Equity Ratio | 65.6% |
How did ASKER perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 04:17 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Asker Healthcare Group AB is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christoph Blieffert | BNP Paribas Exane |
| null null | Danske Bank |
| Erik Cassel | Danske Bank |